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Tyrosine phosphorylation
Tyrosine dephosphorylationT-cell protein tyrosine phosphatase, TCPTP, is a ubiquitously expressed non-receptor type tyrosine phospha-
tase. There are two splice variants of TCPTP, TC48 and TC45, which differ in their sub-cellular localizations
and functions. TC45 is a nuclear protein, which has both nuclear and cytoplasmic substrates, and is involved
in many signaling events including endocytic recycling of platelet-derived growth factor β-receptor. TC48 is a
predominantly endoplasmic reticulum (ER)-localizing protein, which dephosphorylates some of the sub-
strates of TC45 at the ER. However, recently few speciﬁc substrates for TC48 have been identiﬁed. These
include C3G (RapGEF1), syntaxin 17 and BCR-Abl. TC48 moves from the ER to post-ER compartments, the
ER–Golgi intermediate compartment (ERGIC) and Golgi, and it is retrieved back to the ER. The retrieval of
ER proteins from post-ER compartments is generally believed as a mechanism of targeting these proteins
to the ER. However, it is possible that this shuttling of TC48 serves to regulate signaling in the early secretory
pathway. For example, TC48 dephosphorylates phosphorylated C3G at the Golgi and inhibits neurite out-
growth. TC48 interacts with and dephosphorylates syntaxin 17, which is an ER and ERGIC-localizing protein
involved in vesicle transport. A yeast two-hybrid screen identiﬁed several unique interacting partners of
TC48 belonging to two groups — proteins involved in vesicle trafﬁcking and proteins involved in cell adhe-
sion. These interacting proteins could be substrates or regulators of TC48 function and localization. Thus,
the role of TC48 seems to be more diverse, which is still to be explored.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Protein tyrosine phosphorylation is a reversible mechanismwhich
is controlled by two sets of enzymes, protein tyrosine kinases (PTK)
and protein tyrosine phosphatases (PTP). Signaling by protein tyro-
sine phosphorylation plays a pivotal role in regulating many biologi-
cal processes including cell growth, proliferation, motility, adhesion,
differentiation and development, cell death, signal transduction, cyto-
skeletal function, vesicle trafﬁcking, metabolism and others [1–3].
Hence, proper coordination between signals generated by protein
tyrosine phosphorylation and attenuation of signals by protein tyro-
sine dephosphorylation is essential for maintaining a healthy cellular
physiology. Any abnormalities in this coordination can lead to patho-
genesis of various inherited or acquired human diseases such as dia-
betes, autoimmunity and cancer [4–9].ticulum; ERGIC, ER–Golgi inter-
RE, soluble N-ethylmaleimide-
localization signal; PTK, protein
TCPTP, T-cell protein tyrosine
+91 40 27160591.
artment of Cell Biology, 10550
rights reserved.TCPTP is a classical non-receptor type PTP (encoded by Ptpn2 gene)
and was ﬁrst cloned from human T-cell cDNA library [10]. TCPTP gene
maps to the chromosome 18p11.2–11.3 in humans, which is in synteny
with murine TCPTP locus [11]. It is expressed ubiquitously in embryonic
and adult tissues, with highest expression seen in hematopoietic tissues
[10,12]. TCPTP functions in regulating various signal transduction path-
ways in hematopoietic aswell as non-hematopoietic cells. Recent studies
have shown that some of the TCPTP-interacting proteins are localized in
the Golgi and ER and have a role in membrane vesicle trafﬁcking. In this
reviewwe have highlighted the emerging role of TCPTP in the organelles
of the early secretory pathway and in membrane vesicle trafﬁcking.
2. TCPTP splice variants and sub-cellular location
The ﬁrst human TCPTP isoform cloned was a 415 aa protein
(Mr 48,000 Da) [10]. Alternate splice variants, which differ in the
C-terminal region were identiﬁed in rat and mouse cells [12–14]. Four
alternate splice variants of TCPTP were identiﬁed in rat cells — PTP-S1,
PTP-S2, PTP-S3, and PTP-S4, of which PTP-S2 (TC45) and PTP-S4
(TC48) were the major forms. In human cells, only two splice variants
were found — TC45 (PTP-S2) and TC48 (PTP-S4) due to loss of internal
splice site by mutation [15]. TC45 and TC48 differ in their C-terminal
regions (Fig. 1A). TC45 is generated by a unique exon at the 3′ terminus
of the TCPTP gene, which codes for 6 hydrophilic amino acids. TC48 is
Fig. 1. TCPTP domain structure and localization. Left panels, schematic showing domain structures of TC48 and TC45. The DNA-binding domain encompasses nuclear localization
signals. Right panels, representative confocal images show the localization of GFP-TC48 (upper panel) and GFP-TC45 (lower panel) in COS-1 cells after 24 h of overexpression. Scale
bar 10 μm.
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timate exon and an extension of the 3′ intron. This results in replace-
ment of C-terminal 6 amino acids of TC45 with 34 amino acids
(mostly hydrophobic) in TC48. A well characterised bipartite nuclear
localization signal (NLS) is present in both the splice variants at the
C-terminus of the catalytic domain [16,17]. TC45 localizes to the nucleus
by virtue of the NLS (Fig. 1B) [15–19]. Signals stimulated by certain
stress conditions, DNA replication stress and signals from epidermal
growth factor, insulin, TNF-α and IFN-γ are known to cause nuclear
exit of TC45 [20–27]. TC48, in contrast, predominantly localizes to the
endoplasmic reticulum (ER) (Fig. 1B) as the NLS is masked by the
C-terminal extension. TC48 does not have a classical ER retention
motif, but the hydrophobic tail and the region between 346 and 358
amino acids act in concert for proper ER retention of TC48 [16]. Removal
of the hydrophobic domain makes TC48 cytosolic and nuclear and
hence is required for anchorage of the protein to the ER membrane.
The ER localization of TC48 is maintained by selective retrieval from
post-ER compartments, which is mediated by C-terminal 66 amino
acids [28]. Unlike TC45, TC48 does not bind to DNA but it is associated
with the nuclear matrix [18,19]. However, the functional signiﬁcance
of these associations is not clear. Recently it has been shown that the
endogenous TCPTP nuclear staining increases when rat ﬁbroblast cells
are irradiated by UV rays, whereas, nuclear staining decreases and
cytoplasmic staining increases when cells are treated with hydroxy-
urea, which blocks DNA replication. This suggests that the association
of TCPTP isoforms with nuclear components may be involved in DNA
repair and replication [25].
TCPTP is most similar to another intracellular PTP, PTP1B. It shows
72% identity and 86% similarity with PTP1B in the catalytic domain.
PTP1B shows ER localization like TC48 and it shares many substrates
with TC45. When the crystal structures of catalytic domains of TC45
and PTP1B were compared, it was found that they have virtually iden-
tical catalytic sites [29,30]. Though PTP1B shows similarity to TCPTP,
there are extensive differences in their substrate selectivity and func-
tions. This aspect has been discussed in an excellent review by Tiganis
[31].3. TC45
3.1. Substrates and functions of TC45
TCPTP is shown to be involved in several signaling pathways and sev-
eral substrates of TC45 have been identiﬁed. These include a) receptor
tyrosine kinases (RTKs) such as insulin receptor [20,32], epidermal
growth factor (EGF) receptor [33], platelet-derived growth factor
(PDGF) receptor [34], colony-stimulating factor-1 (CSF) receptor [35],
vascular endothelial growth factor (VEGF) receptor [36] and Met-
receptor tyrosine kinase [37], b) nuclear proteins such as STAT1, STAT3,
STAT5 and STAT6 [38–41], c) cytoplasmic proteins such as JAK1 and
JAK3 [42], p52Shc [33], Src tyrosine kinases [43,44] and Caveolin-1 [45].
High expression of TCPTP in hematopoietic tissues indicated
towards its role in immune signaling and development of hematopoi-
etic lineages. Loss of TCPTP is not embryonic lethal but TCPTP−/−
mice die within 3–5 weeks of age. TCPTP−/− knockout mice suffer
from severe anemia, splenomegaly, lymphadenopathy and thymic
atropy [46]. The role of TCPTP in immune signaling has been
described in detail in an excellent review by Trembley's group [47].
TCPTP is also an important regulator in insulin signaling. Insulin
receptor is a direct substrate of TCPTP and attenuates the signal initi-
ated by insulin [20,32]. Many studies using substrate-trapping
mutant of TCPTP (TCPTP D182A), RNAi against TCPTP and Ptpn2−/−
knockout ﬁbroblast have shown that TCPTP is an effective negative
regulator of the insulin signaling [31,48]. However, in vivo studies
using Ptpn2−/− mice have not been possible due the early death of
these mice. Recently, the role of TCPTP in glucose homeostasis has
been shown by using Ptpn2+/- heterozygous mice [49]. Hepatocytes
from Ptpn2+/- mice showed increased insulin receptor phosphoryla-
tion, PI3K/Akt signaling and IL-6 induced STAT3 phosphorylation.
There was reduced hepatic glucose production and reduced expres-
sion of gluconeogenic genes G6pc and Pck1. This showed the role of
TCPTP in attenuating the signal initiated by insulin and IL-6, which
is required for regulating gluconeogenic gene expression and hepatic
glucose output.
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in genome-wide association scan [24]. Type-I diabetes is primarily
caused because of destruction of insulin-producing pancreatic
β-cells by inﬂammatory response evoked by Fas ligand and cytokines,
such as IL-1, TNF-α and IFN-γ. TCPTP has been shown to regulate
IFN-γmediated signaling [50] as well as the JAK/STAT signaling path-
way as JAK1 and STAT1 are known substrates of TC45. Indeed it was
observed that knockdown of TCPTP aggravated cytokine-induced
β-cell apoptosis as a result of enhanced IFN-γ-induced STAT1 and
STAT3 phosphorylation [24]. TCPTP mRNA and protein expression
was also upregulated when human islets and rat primary and immor-
tal β-cells were treated with IL-1 and IFN-γ in turn suggesting the
protective role of TCPTP in inﬂammatory conditions. TCPTP along
with PTP1B has also been shown to modulate ER-stress in pancreatic
β-cells by regulating Src family kinase [51]. Though the role of TCPTP
in insulin signaling was known but its role in diabetes is slowly
emerging.
Genetic variations in PTPN2 gene have also been associated with
other chronic inﬂammatory diseases such as Crohn's disease (CD)
[52–54]. CD is a chronic intestinal inﬂammatory disease caused by
several factors, which lead to defective epithelial barrier and dysfunc-
tional immune response to intestinal ﬂora. Autophagy has been
shown to play an important role in clearance of pathogens and in
developing host immune response [55,56]. Recently it has been
shown that knockdown of PTPN2 impairs cytokine-induced expression
of autophagy related genes and results in impaired autophagosome for-
mation and increased apoptosis in human intestinal epithelial cells
(IEC) [57]. Similarly, intestinal ﬁbroblast cells isolated from CD patient
with PTPN2 variant showed less autophagosome formation compared
to cells with wild-type PTPN2. Cells treated with siRNA against PTPN2
or cells from CD patient with PTPN2 variant also showed defective path-
ogen clearance suggesting the role of PTPN2 in autophagy. When IEC or
THP-1 cells in which PTPN2-variant rs1893217 was exogenously intro-
duced, were treated with muramyl-dipeptide (autophagy inducer),
they showed lesser number and larger autophagosomes compared to
cells having wild-type PTPN2 [58]. The role of PTPN2 in autophagy has
been covered in detail in a recent review [59]. CD is also characterized
by elevated levels of cytokines and their subsequent signaling events
which could lead to defective intestinal epithelial barrier because of
increase in the expression of the pore-forming claudin proteins [60].
TCPTP plays a protective role as its expression increases when IEC are
treated with IFN-γ [27] or with TNF-α [26]; it is known to down-
regulate IFN-γ-induced signaling events. TCPTP knock-down in IEC
enhanced IFN-γ-induced STAT1 and STAT3 phosphorylation and
increased epithelial permeability as well as claudin-2 expression [27].
TCPTP knock-down in IEC also enhanced TNF-α-induced inﬂammatory
response [26]. Similarly, TCPTP also regulates function of EGF receptor
in IEC and its dysfunction can alter EGF receptor-mediated signaling
including regulation of EGF-induced chloride secretion [61]. TCPTP
also regulates IFN-γ-induced cytokine signaling in the humanmono-
cytic cell line THP-1 [62] and its loss enhanced the secretion of the
proinﬂammatory cytokines interleukin-6 (IL-6) and macrophage
chemoattractant protein 1. Thus, it is clear that dysfunction of
TCPTP can contribute to pathogenesis of CD by regulating several sig-
naling pathways. However, the role of individual isoforms of TCPTP,
TC45 and TC48, is yet to be determined in CD and autophagy.
Integrins are collagen receptors that control cellular signaling pro-
cesses by regulating anchorage-dependent receptor tyrosine kinase sig-
naling and are important molecules, which are required for cellular
adhesion to extra cellular matrix. Integrin signaling seems to play an
important role inmany human cancers. Cytoplasmic domain of integrin
α1β1 has been shown to selectively interact with TC45 and activate it.
Activated TC45 in turn dephosphorylates EGF receptor and down-
regulates its signaling stimulated by EGF. Phosphorylation of EGF recep-
tor also increased when TCPTP was downregulated by siRNA. This
shows the role of TCPTP in integrin-mediated negative regulation ofreceptor tyrosine kinase signaling [63]. Recently, it has been shown
that Caveolin-1 is a direct substrate of TC45 [45]. Caveolin-1 is an impor-
tant component of the caveolae arising from the plasma membranes
and is known to negatively regulate integrin-mediated signaling,
TGF-β signaling, as well as EGF receptor-mediated signaling [64–66]. It
is in fact shown that TC45 dephosphorylated Caveolin-1 in integrin
α1β1-dependent manner [45]. TC45 overexpression decreased pCav-1
levels only in CHO cells (lacking endogenous integrinα1β1) transfected
with integrin-α1 and not in cells transfected with empty vector.
Integrin α1β1 directly interacted with Caveolin-1 and TC45 directly
dephosphorylated Caveolin-1. Hence, TCPTP is involved in many
integrin-dependent signaling events.
TCPTP is also known to regulate TNF-α signaling. TNF-α can elicit
varying responses which are mainly mediated through NF-kB and
MAPK signaling pathways. TRAF-2 is an adaptor protein which has
been shown to be involved in both the TNF-α signaling pathways.
TCPTP was shown to interact with TRAF-2. TCPTP−/− mouse embryo
ﬁbroblasts (MEFs) showed enhanced Erk1/2 (effector molecule of
MAPK pathway) phosphorylation upon TNF induction when com-
pared to TC45 or TC48 reconstituted TCPTP−/− MEFs but there was
no effect on Jnk and p38 kinase, or the NF-kB signaling. Src-tyrosine
kinase inhibitor reduced Erk1/2 phosphorylation in TNF induced
TCPTP−/− MEFs and had no effect on NF-kB pathway. This suggested
that TCPTP is involved in regulating TNF-α-induced Erk mediated
signaling speciﬁcally [43]. TCPTP overexpression suppressed the acti-
vation of Erk1/2 and p38 that was mediated by the constitutively
active Src-Y527F; TCPTP-D182A ‘substrate-trapping’ mutant could form
a complex with tyrosine-phosphorylated Src-Y527F. This suggested
that SFKs are involved in TNF-inducedMAPK signaling and are substrates
for TCPTP [43]. Thus, TCPTP is an integral regulator of TNF meditated
signaling.
3.2. Role of TCPTP in endocytic recycling
PDGF receptor is a substrate for TCPTP [34]. Unlike EGF receptor,
PDGF receptor is not known to recycle; after stimulation it is degrad-
ed via the lysosomal pathway, though small fraction of the receptor
may still be recycled [67]. TCPTP knockout mouse embryonic ﬁbro-
blasts (MEFs) show hyperphosphorylation and delayed degradation
of PDGF β-receptor [68]. Loss of TCPTP caused delayed clearance of
surface PDGF β-receptor, which was not due to delayed receptor
internalization. When TCPTP−/−MEFs were treated with an inhibitor
of receptor recycling, monensin, the rate of PDGF receptor clearance
increased and was comparable with TCPTP+/+ MEFs. This suggested
that loss of TCPTP actually increased rate of recycling of PDGF
β-receptor to the surface. PDGF receptor colocalized with Rab4 in
TCPTP−/− MEFs which is involved in rapid endocytic recycling path-
way. This effect on recycling upon loss of TCPTP was speciﬁc to PDGF
β-receptor homodimers or heterodimers and not for PDGFα-receptor
homodimers though PDGF α-receptor is also a substrate for TCPTP.
This suggested the role of TCPTP in endocytic pathway; however the
role of TC48 has not been investigated.
4. TC48
4.1. Substrates of TC48
Several substrates of TC45 have been identiﬁed but the role of TC48
is less understood. TC48 has been shown to dephosphorylate the recep-
tor tyrosine kinases — EGF receptor, insulin receptor and Met-receptor
tyrosine kinases [20,33,37] (Fig. 2). Endogenous EGF receptor showed
punctate staining in cells overexpressing substrate-trapping mutant of
TC48, TC48–D182A [33]. TC48–D182A, like TC48, showed ER-like retic-
ular staining pattern and the EGF receptor puncta colocalized with
TC48–D182A. It is postulated that the function of TC48 might be to
prevent the nascent RTKs, which are undergoing posttranslational
Fig. 2. Substrates of TC48. TC48 localizes to the endoplasmic reticulum (ER), ER–Golgi intermediate compartment (ERGIC) and the Golgi. The receptor tyrosine kinases (RTKs),
insulin receptor (IR), epidermal growth factor receptor (EGFR) and c-Met tyrosine kinase receptor (c-Met), are substrates of TC48. TC48 is probably involved in preventing
ligand-independent stimulation of nascent RTKs in the endoplasmic reticulum during their synthesis and post-translational modiﬁcations. Syntaxin 17 which localizes to the ER
and ERGIC, phosphorylated-C3G which localizes to the Golgi and cytoplasmic BCR-Abl are speciﬁc substrates of TC48.
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the cells. EGF receptor has been shown to be mutated frequently in
malignant brain tumour glioblastoma; p140EGFR mutant has been
shown to be constitutively active and is mislocalized to the ER [69].
Another function that has been attributed to ER-localized TC48 is to
attenuate signals initiated by suchmutant RTKs, which aremislocalized
to the ER [33]. Generally, once the ligands bind to their RTKs and initiate
downstream signaling pathways, the RTKs are dephosphorylated, inter-
nalized by endocytosis and are either degraded or recycled back to the
plasma membrane for new signaling events [70]. However, since the
ligand is still bound to the RTKs in the endosomes, signaling might
still take place. It is also presumed that the ER-localized TC48 might
have access to endocytosed RTKs [20]. These RTKs are also the
substrates of TC45. Till recently, unique substrates for TC48 had not
been identiﬁed. The only unique substrates of TC48 which have been
identiﬁed are 1) C3G (RapGEF1), a guanine nucleotide exchange factor
[71,72],2) syntaxin 17, a SNARE (soluble N-ethylmaleimide-sensitive
factor attachment protein receptor) family protein [73] and 3)
BCR-Abl [74] (Fig. 2). C3G was shown to be dephosphorylated speciﬁ-
cally by TC48 and not by TC45 in human neuroblastoma cell line,
IMR-32, though C3G was shown to interact with both the isoforms
through the common C-terminal 350-381 amino acid residues [71].
Similarly, though BCR-Abl interacts with both TC48 and TC45, it is
dephosphorylated by TC48 only [74]. TC48 was shown to speciﬁcally
interact with and dephosphorylate the oncogenic protein kinase,
BCR-Abl, and not the cellular Abl kinase. Overexpression of TC48 in
K562 cells (a cell line derived from chronic myeloid leukemia patient,
which is positive for BCR-Abl) inhibited cell proliferation and enhancedsensitivity towards STI571, a drug used in the treatment of chronic
myeloid leukemia. This suggested the role of TC48 in suppression of
malignancy.
4.2. Cycling of TC48 between the ER and Golgi
It has been shown that TC48 cycles between the ER and the post-ER
compartments – the ER–Golgi intermediate compartment (ERGIC) and
the Golgi [28]. TC48 shows signiﬁcant colocalization with Golgi marker
(Giantin) and ERGIC marker (ERGIC-53) after 12 hrs of overexpression
in COS-1 cells. TC48 also accumulates in the 15°C compartment
(ERGIC). Another important observation was that when C-terminal 40
amino acids of TC48 were tagged to GFP (GFP-C40) it showed predom-
inant Golgi localization. This observation shows that ER-export motif
and Golgi localization signal are present in the C-terminal 40 amino
acid sequence of TC48. However, its steady state localization in the ER
is maintained by selective retrieval from post-ER compartments [28].
A yeast two-hybrid screening of human placental cDNA library using
human TC48 as a bait showed that TC48 interacted with p23 and p25
(type-I transmembrane proteins) which belong to the p24 family.
These p24 family members are cargo receptors and are the major com-
ponents of vesicles moving between the ER and the Golgi. p24 proteins
interact directly with COPII (involved in anterograde transport from the
ER to the Golgi) and COPI (involved in retrograde transport from
post-ER compartments to the ER) coated vesicles, thus facilitating
their cycling between the ER and post-ER compartments [75]. Direct
interaction of TC48 with p25 seems to be important for targeting TC48
to the ER. This was based on the following observations, 1) p25
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acids, which is sufﬁcient to target TC48 to the ER; C-terminal 40
amino acids of TC48, which target GFP to the Golgi, were not sufﬁcient
for interaction with p25, 2) coexpression of p25 enhances ER localiza-
tion of TC48, 3) in the presence of a mutant of p25 defective in ER
retrieval dilysinemotif, TC48 showedmore Golgi localization. The inter-
actionwith p23, on the other hand,might be important for exit from the
ER or to target TC48 to the Golgi. This is supported by the fact that
C-terminal 40 amino acids of TC48, which are sufﬁcient for interaction
with p23, target GFP to the Golgi. Hence, the interaction of TC48 with
p24 family members, p25 and p23, is involved in the cycling, localiza-
tion to the post-ER compartments and retrieval of TC48 to the ER [28].4.3. Why TC48 moves to the Golgi?
Does TC48 have a function in the Golgi? It has been shown earlier
that C3G, a guanine nucleotide exchange factor, gets phosphorylated
on tyrosine by the activity of Src kinases and by stimulation of endog-
enous kinases upon pervanadate treatment; phosphorylated C3G
localizes to the Golgi [76]. C3G, generally, shows a diffuse cytoplasmic
staining but upon tyrosine phosphorylation shows prominent Golgi
localization. This could be due to two factors; either Golgi localized
kinases phosphorylate C3G or phosphorylated C3G is targeted to the
Golgi. Hence, it is likely that phosphorylation of C3G is regulated at
the Golgi. Recently, it has been shown that C3G interacts with TC48
and is a substrate of TC48 [71]. TC48 overexpression inhibits Src-
induced and pervanadate-induced tyrosine phosphorylation of C3G
and Golgi localization of C3G is lost. GFP tagged substrate-trapping
mutant of TC48, GFP-TC48-D182A, colocalized with phosphorylated
C3G in the Golgi. This is perhaps the ﬁrst function of TC48 identiﬁed
at the Golgi. Dynamic shuttling of TC48 between the ER and Golgi is
likely to be involved in regulating the activity of C3G at the Golgi
required for differentiation of neuroblastoma cells [71].4.4. Identiﬁcation of novel interacting partners of TC48
TC48 though predominantly present in the ER, is also found in the
ERGIC and the Golgi. However, the role of TC48 in the early secretory
pathway is not clear. With the aim of understanding the function of
TC48 by identifying novel interacting partners of TC48, a yeast
two-hybrid screening was carried out using TC48 as bait [28,73].
Many unique interacting partners of TC48 were identiﬁed that did
not interact with the other isoform, TC45. There were two major clas-
ses of TC48-interacting proteins – a) proteins involved in vesicular
trafﬁcking such as Syntaxin 17 [73,77–79], p24 family members p23
and p25 [28,75], Golgi-associated protein GCP60 [80], reticulon 3
(an ER resident protein) [81,82] and VAP-33 (a SNARE-interacting
integral membrane protein) [83,84], and b) proteins involved in cell
adhesion such as PECAM-1 [85–88], GPNMB [89,90], CRELD1
[91,92], JAM-2 [93,94] (Table 1). PECAM1 is known to be phosphory-
lated on tyrosine [86,88] and has been shown to act as a scaffolding
protein and regulate several signaling pathways [85,87].
GCP60 is a coiled coil domain containing tethering factor, which is
required for maintenance of the Golgi structure and also has a role in
protein transport between the ER and Golgi [80]. GCP60 interacts
with C-terminal 40 amino acids (376–415) of TC48 that are sufﬁcient
for targeting of GFP to the Golgi. Therefore, it could be involved in
Golgi localization/anchoring of TC48. In fact TC48 shows good
colocalization with overexpressed GCP60, which is present mostly
in the Golgi. It appears that GCP60 expression enhances Golgi locali-
zation of TC48. GCP60 gets phosphorylated at tyrosine and therefore,
it could be a substrate of TC48 (V. Gupta and G. Swarup, unpublished
observations) but the functional signiﬁcance of this phosphorylation
is not known.5. TC48, a putative regulator of vesicular trafﬁcking
As many of the TC48-interacting proteins identiﬁed are involved in
different aspects of intracellular vesicle transport, it is likely that TC48
plays a role in regulating certain steps of vesicular trafﬁcking. Interaction
with p24 family members, as described earlier, was shown to be impor-
tant for cycling of TC48 in the early secretory pathway and targeting of
TC48 to the ER [28]. Recently, it has been shown that the SNARE protein,
syntaxin 17, can get phosphorylated on Tyr-156 (Tyr-157 in human) and
is a direct substrate of TC48 [73]. SNARE proteins are generally involved
inmediating fusion of vesicles with their acceptormembranes and regu-
lating membrane dynamics in eukaryotic cells [95–99]. Syntaxin 17,
though ubiquitously expressed, is abundant in steroidogenic cell types
and localizes predominantly in the ER and to a lesser extent in the
ERGIC; it is required for maintaining the architecture of the ERGIC and
Golgi [77–79]. Syntaxin 17 was also identiﬁed in a siRNA screen as a
SNARE required for constitutive secretion [100]. Tyrosine phosphoryla-
tion of syntaxin17 is tightly regulated as it is highly cell type speciﬁc
(till now found only in CHO and MIN6 cells) [73]. Compared to
wild-type syntaxin 17, a phospho-mimicking mutant of syntaxin 17,
Y156E-Syn17, shows less interaction with COPI vesicle component,
β-COP. Overexpression of syntaxin 17 results in dispersal of β-COP
staining whereas overexpression of Y156E-Syn17 or pervanadate-
induced phosphorylation of wild-type syntaxin 17 reduces β-COP dis-
persal [73]. These ﬁndings suggested that phosphorylation of syntaxin
17 may regulate vesicular trafﬁcking events of the early secretory path-
way. Likewise, TC48 being a phosphatase of syntaxin 17, may regulate
tyrosine phosphorylation-dependent functions of syntaxin 17, thereby
affecting intracellular vesicular transport.
Generally, overexpressed GFP-TC48 shows a reticular staining pat-
tern, which is typical for ER resident proteins, in most of the cells. How-
ever, few TC48 expressing cells show vesicular structures due to high
expression levels. When substrate trapping mutant GFP–TC48–D182A
is overexpressed, inmost of the cells it showed large vesicular structures
along with reticular ER pattern (Fig. 3). Some of these large vesicular
structures colocalized with the ER marker, calnexin (Fig. 3), suggesting
that these are ER-derived structures. It is possible that overexpression
of substrate-trappingmutant of TC48 is disturbing vesicle fusionprocess-
es in the cell which is resulting in the formation of larger vesicles. The
identity of these vesicles is yet to be established. We also observed that
in some cells GFP–TC48–D182A showed vesicular staining along the
periphery of the cell probably near the plasma membrane. PTP1B, a
homologue of TC48, which is also an ER-localizing protein, is known to
interact with insulin receptor in recycling endosomes to downregulate
it [101]. PTP1B catalyzed dephosphorylation of EGF receptor and PDGF
receptor has been shown to require endocytosis of the receptors [102].
How PTP1B downregulates RTKs has been elaborately reviewed by
Tremblay's group [103]. Recently, the role of PTP1B in degradation of
Met-tyrosine kinase receptor andEGF receptor through endosomal path-
way has also been shown [104]. PTP1B in fact is required for dephos-
phorylation of N-ethylmaleimide-sensitive factor (NSF) [105], which is
an essential component of vesicle fusion machinery, and this interaction
is also required for proper trafﬁcking of endocytosed RTKs and signal
attenuation [104]. Similarly, we suspect that TC48 might also have a
role in endocytosis or it might interact with its substrate RTKs in this
pathway.
6. Concluding remarks
Although TC48 was the ﬁrst PTP to be cloned, progress in under-
standing its function has been slow and difﬁcult. This is partly due
to the fact that as compared to TC45 isoform, TC48 is generally
expressed at lower level. Secondly, no speciﬁc antibody is available
to recognise TC48 or TC45 isoform. In TCPTP knockout cells/mice
both the isoforms are knocked out. Therefore, the contribution of
TC48 in the defects observed in TCPTP knockout cells and mice is
Table 1
Proteins which interact with TC48.
Name Interaction with Function Tyrosine
phosphorylation
References
TC48 TC45
EGF receptor Yes Yes Receptor involved in EGF-mediated signal transduction Yes [33]
Insulin Receptor Yes Yes Receptor involved in insulin-mediated signaling Yes [20]
c-Met tyrosine kinase Yes Yes Receptor involved in human growth factor-mediated signaling Yes [37]
p23 Yes No Cargo receptor (Involved in cycling between ER and Golgi) No* [28]
p25 Yes No Cargo receptor (Involved in cycling between ER and Golgi) No* [28]
Syntaxin 17 Yes No SNARE protein (Involved in mediating vesicle fusion processes) Yes [73]
GCP60 Yes No Golgi structural protein, has role in ER to Golgi protein transport Yes *
Reticulon 3 Yes No ER protein involved in ER morphology and membrane trafﬁcking No** *
VAP33 Yes No SNARE interacting proteins involved in vesicle trafﬁcking ND *
C3G Yes Yes# GEF implicated in pathways triggered by growth factors, adhesion
receptors, cytokines and others
Yes [71]
BCR-Abl Yes Yes# Oncogene involved in the progression of leukemia Yes [74]
PECAM1 Yes No Cell-adhesion molecule implicated as activator of integrins and
suppressor of cell-death
Yes *
GPNMB Yes No Melanosome-associated glycoprotein
A gene involved in human pigmentary glaucoma
ND *
CRELD1 Yes No Cell-adhesion molecule, it is known to interact with Reticulon 3 ND *
JAM2 Yes No Protein enriched at tight junctions and implicated in endothelial
cell polarity
ND *
ND, not determined; * V Gupta and G Swarup, unpublished; ** M Muppirala and G Swarup, unpublished; #, these are not dephosphorylated by TC45 in the cells.
1130 M. Muppirala et al. / Biochimica et Biophysica Acta 1833 (2013) 1125–1132not clear. Most of the reconstitution experiments in TCPTP−/− cells
have been carried out using TC45 isoform and not TC48 isoform.
Since TC48 and TC45 mRNAs have different 3′-UTRs, it should be pos-
sible to knockdown these isoforms selectively to study their role in
cellular functions. Speciﬁc knockout mice for TC48 or TC45 can be
made to study the role of each isoform individually. Identiﬁcation of
novel substrates and interacting proteins has revealed that TC48 is
likely to be involved in regulating signaling and membrane vesicle
trafﬁcking in the early secretory pathway. Dephosphorylation of
C3G at the Golgi by TC48 clearly shows that shuttling of TC48
between the ER and the Golgi serves the function of regulating signal-
ing at the Golgi. Dephosphorylation of syntaxin 17 by TC48 might
regulate syntaxin 17-dependent trafﬁcking. Some of the TC48-
interacting proteins might be involved in regulating its function or
sub-cellular localization. Role of interacting partners in regulating
the enzymatic activity of TC48 has not been investigated. FunctionalFig. 3. Substrate-trapping mutant of TC48 (TC48–D182A) forms large vesicles. Some of the
peripheral localization. Representative confocal images show colocalization of GFP–TC48 ansigniﬁcance of its interaction with proteins involved in cell adhesion
is yet to be explored. Overall, the role of TC48 in vesicular trafﬁcking
seems to be slowly emerging; however, further studies are still
required to establish functions of TC48 in the cell.
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